Loading...
XSHE
000504
Market cap425mUSD
Dec 05, Last price  
9.11CNY
1D
1.22%
1Q
-5.89%
Jan 2017
-45.02%
Name

Hunan CCID-Media Investments Co Ltd

Chart & Performance

D1W1MN
XSHE:000504 chart
P/E
—
P/S
22.36
EPS
—
Div Yield, %
—
Shrs. gr., 5y
1.20%
Rev. gr., 5y
0.04%
Revenues
134m
-1.71%
222,488,100227,939,136319,085,934197,455,710178,309,954151,990,36990,893,02776,816,61926,280,91518,372,82813,374,22267,251,43167,392,99095,381,715134,160,531175,564,990156,618,305200,345,457136,790,924134,447,796
Net income
-20m
L-29.56%
2,054,0022,227,4953,668,877006,461,3350013,801,4920021,756,0980018,806,36814,635,46500-28,172,625-19,846,018
CFO
5m
-86.79%
11,397,589717,6159,215,819060,277,6980000000-47,403,365014,522,3620107,098,005166,381,24336,276,7134,793,582
Dividend
Apr 23, 20040.023077 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

NanHua Bio-medicine Co., Ltd. provides stem and immune cell storage, noninvasive genetic testing, and biological research and technical services. The company is based in Changsha, China.
URL
http://www.nhbiogroup.com/
IPO date
Dec 08, 1992
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT